drugset / Trial / NCT02515955

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Healthy Male Participants

NCT02515955

Phase 1 Completed 76 enrolled Janssen-Cilag International NV
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the safety, tolerability and pharmacodynamics of JNJ-54175446 after multiple consecutive dose administrations

Timeline

Start
2015-08
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-54175446 Small molecule 0.5 mg/ml Oral
Subject JNJ-54175446 Small molecule 20 mg/ml Oral
Subject Minocycline Small molecule 100 mg Oral
Background Dextroamphetamine Small molecule 20 mg

Indications

No indication recorded.